This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Medivir Ab. Active years: 1999-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Enhõrna, SE (2009)
- Enhörna, SE (2010)
- Enhorna, SE (1999 - 2012)
- Huddinge, SE (2010 - 2012)
Company Filing History:
Years Active: 1999-2012
Title: Innovation and Impact: The Patents of Nils-Gunnar Johansson
Introduction
Nils-Gunnar Johansson is a distinguished inventor based in Huddinge, Sweden. With a remarkable portfolio comprising 12 patents, he has made significant contributions in the field of pharmaceuticals, particularly focusing on antiviral treatments.
Latest Patents
Among his latest inventions are two innovative patents that showcase his expertise in combating hepatitis C virus (HCV). The first patent involves antiviral nucleosides, specifically 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydrofuran-2-yl)-1H-pyrimidin-2-one, which acts as a polymerase inhibitor for HCV. This groundbreaking work also involves the development of compositions and methods for inhibiting HCV and treating related diseases. Additionally, he has patented methods and novel intermediates for the preparation and treatment of acyclic nucleoside derivatives, further advancing the field of antiviral drugs.
Career Highlights
Nils-Gunnar Johansson has built a successful career at Medivir AB, where his research and development efforts have significantly propelled innovations in antiviral therapies. His work is not only scientifically significant but also reflects a commitment to improving public health outcomes through effective medications.
Collaborations
Throughout his career, Johansson has collaborated with notable colleagues, including Per Engelhardt and Marita Hogberg. These partnerships have been instrumental in driving forward his research and enhancing the impact of his patents in the pharmaceutical industry.
Conclusion
In summary, Nils-Gunnar Johansson stands as an influential figure in the realm of antiviral innovation. His extensive patent portfolio, particularly regarding hepatitis C treatments, underscores his dedication to advancing medical science and improving health outcomes for patients around the globe. His contributions continue to inspire future generations of inventors and researchers in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile